Navigation Links


Electroconvulsive in Medical News

Study Shows NeuroStar TMS Therapy(R) Improved Key Elements of Cognition in Patients with Major Depressive Disorder

... Unlike electroconvulsive Therapy (ECT), NeuroStar TMS Therapy Is Not Associated With Memory Loss ... depression treatments, such as some classes of medications. Most notably, electroconvulsive therapy (ECT), while extremely effective, has high rates of cognitive ...

Antidepressants aid electroconvulsive therapy in treating severe depression

... WINSTON-SALEM, N.C. Combining antidepressant drugs with electroconvulsive therapy (ECT) does a better job of reducing symptoms of severe depression and causes less memory loss than using ECT alone, according to a new study ...

Brain Stimulation Therapy Eases Tough-to-Treat Depression

... suffering from depression get no relief from psychotherapy and/or medication. About 70 percent of these "non-responders" can, however, benefit from electroconvulsive therapy. But many of these will later relapse, and there's still the group of individuals who fail all treatments. For this trial, a dozen ...

Promising results in deep brain stimulation for patients with treatment-resistant depression

... the patient. Only patients who were unable to get better with most other types of antidepressant treatment including medication, psychotherapy and electroconvulsive therapy were included in the study. "In previous studies using brain imaging, we found the subcallosal cingulate region was a key region in an ...

New form of ECT is as effective as older types but without cognitive side effects

... Philadelphia, PA, May 27, 2008 - In a study appearing in the new issue of BRAIN STIMULATION, scientists report that a new form of electroconvulsive therapy (ECT) is just as effective as older forms in treating depression but without any of the cognitive side effects found in the older forms. In ...

Study shows new strategy for developing antidepressants

... in a difficult to treat group, meaning individuals who had not responded to other treatments including psychotherapy, traditional antidepressants or electroconvulsive therapy. This group did not attempt all treatment options, like medication. Researchers treated the depressed patients intravenously with ketamine, a ...

Antidepressant drugs best for treating Depression

... treatment for moderate to severe depression is antidepressant and electroconvulsive therapy. // Though there are various reports finding links between use of ... options available for treating depression is antidepressant drugs and electroconvulsive ....

Implanting Electrodes in the Brain Could Help Treat Severe Depression

... implanted the system into three individuals who experienced major depression and who had not responded to other treatments, including drugs of electroconvulsive therapy. All the patients reported that they sensed no sensations when the stimulator was turned on. They also reported that they felt no ...

Vagal Nerve Stimulation Works To Treat Severe Depression

... to be effective, he added. ‘This is very different from the delays we see with existing treatments for depression, including pharmacotherapy and electroconvulsive therapy (ECT),’ Dr. Conway said. ‘The biggest changes in the brain that we're noting occur between 12 and 24 months after patients began receiving ...

Scientists Identify Gene Responsible For Depression

... levels of p11 protein in both cases. On the other hand, p11 levels increased in rats and mice that were treated with anti-depressant medications or electroconvulsive therapy. To further test the connection, the researchers genetically engineered two strains of mice: one that produced more p11 than normal ...

FDA Approved Nerve-Stimulation Therapy Now Available In New York

... every year and more than 4 million people do not respond to conventional treatment such as psychotherapy, antidepressant medications, and even electroconvulsive therapy. Nearly half of patients with an average of 25 years of major depressive disorder and multiple treatment trials realized some clinical ...
Other Contentsexocrineexocrineexogenousexogenousexogenousexogenousexogenousexogenousexonsexonsexonsexonsexoskeletonexoskeletonexonucleaseexonucleaseexonucleaseexpressexpressexpressexpressexpressexpressexpressexpressextantextant
Breaking Biology News(10 mins):Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research 2Genome BC collaborates with Chile and Norway to sequence salmon genome 2Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 1Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 2Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 1Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 2Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 3Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 4Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 5Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 6Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 7Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 8Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 9Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 10Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 11Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 12Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 13Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 14Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 15Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 16Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 17Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 18Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 19Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 20Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 21Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 22Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 23Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 24Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 25Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 26Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 27Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 1Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 2Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 3Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 4Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 5Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 6Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 7Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 8Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 9Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 10Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 11Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 12Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 13Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 14
Other TagsLuresHiltonJoseOther Tagsreside 2reside 3hemorrhagic 2